GlassScriptPhysician profile
Laura Suhan
NPI 1053866319
$3,266.84
in general payments reported to CMS, 2019-2025
34 companies · $1,096 in 2025
The $1,096 reported for 2025 was more than what 86% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $287 · 2022: $573 · 2023: $701 · 2024: $610 · 2025: $1,096.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,407.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,406.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $804.84 | 2021-2025 | Briviact, Fintepla, Zilbrysq |
| Sk Life Science, INC. | $393.61 | 2022-2025 | |
| Abbvie INC. | $295.61 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $210.02 | 2021-2025 | Wainua |
| Neurelis, INC. | $180.81 | 2023-2025 | Valtoco |
| Neurocrine Biosciences, INC. | $170.16 | 2025 | |
| Argenx US, INC. | $145.54 | 2022-2025 | Vyvgart Hytrulo |
| Grifols USA, LLC | $119.05 | 2025 | Gamunex-C |
| Alexion Pharmaceuticals, INC. | $87.64 | 2022-2024 | Ultomiris |
| Biogen, INC. | $75.25 | 2022-2025 | Vumerity, Tysabri |
| Horizon Therapeutics Plc | $70.62 | 2022 | |
| Livanova USA, INC. | $68.82 | 2023-2025 | Vns Therapy Sentiva Model 1000 Generator |
| Lilly USA, LLC | $64.59 | 2022-2024 | Emgality, Reyvow |
| Novocure INC. | $60.06 | 2023-2024 | Optune |
| Aucta Pharmaceuticals, INC. | $58.41 | 2024-2025 | Motpoly Xr |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $48.64 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $42.58 | 2021-2022 | |
| Aquestive Therapeutics, INC. | $33.17 | 2022 | |
| Lundbeck LLC | $32.47 | 2024 | Vyepti |
| Celgene Corporation | $31.85 | 2022-2024 | Zeposia |
| Otter Pharmaceuticals, LLC | $29.84 | 2025 | Sympazan |
| Jazz Pharmaceuticals INC. | $28.76 | 2021-2025 | |
| Monteris Medical Corporation | $24.43 | 2022 | |
| Medtronic, INC. | $22.16 | 2022 | |
| Eisai INC. | $21.09 | 2022 | |
| Nxstage Medical, INC. | $19.20 | 2021 | |
| Ebi, LLC | $18.79 | 2025 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Highridge Medical LLC | $18.79 | 2025 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Genentech, INC. | $18.58 | 2021 | |
| Csl Behring | $15.69 | 2025 | Hizentra |
| Ironshore Pharmaceuticals INC. | $14.68 | 2023 | Jornay Pm |
| Janssen Pharmaceuticals, INC | $14.06 | 2022 | |
| Kyowa Kirin, INC. | $13.79 | 2022 | |
| Sumitomo Pharma America, INC. | $13.24 | 2023 | Aptiom |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Suhan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.